Novartis Pharmaceuticals Corporation et al v. Novugen Oncology Sdn. Bhd. et al
| Novartis Pharmaceuticals Corporation, Novartis Pharma AG and Japan Tobacco Inc. |
| Novugen Oncology Sdn. Bhd., Novugen Pharma (USA) LLC and Makro Technologies, Inc. |
| 1:2023cv01449 |
| December 20, 2023 |
| US District Court for the District of Delaware |
| Gregory B Williams |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. ยง 1 Patent Infringement |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on December 27, 2023. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Case Assigned to Judge Gregory B. Williams. Please include the initials of the Judge (GBW) after the case number on all documents filed. (rjb) |
| Filing 8 Summons Issued as to Makro Technologies, Inc. on 12/20/2023; Novugen Oncology Sdn. Bhd. on 12/20/2023; Novugen Pharma (USA) LLC on 12/20/2023. (Attachments: #1 Summons Issued, #2 Summons Issued)(mkr) |
| Filing 7 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Novartis AG for Novartis Pharmaceuticals Corporation filed by Novartis Pharmaceuticals Corporation. (mkr) |
| Filing 6 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Novartis AG for Novartis Pharma AG filed by Novartis Pharma AG. (mkr) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Japan Tobacco Inc. (mkr) |
| Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,378,423; 8,580,304; 9,155,706 ;9,271,941 ;9,399,021. (mkr) |
| Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: November 7, 2023. Date of Expiration of Patent: See Attached.Thirty Month Stay Deadline: 5/7/2026. (mkr) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mkr) |
| Filing 1 COMPLAINT filed against Makro Technologies, Inc., Novugen Oncology Sdn. Bhd., and Novugen Pharma (USA) LLC (Filing fee $ 405, receipt number ADEDC-4298960.) - filed by Novartis Pharmaceuticals Corporation, Novartis Pharma AG, and Japan Tobacco Inc. (Attachments: #1 Exhibit A-E, #2 Civil Cover Sheet) (mkr) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
